Impact Factor
4.56
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
8.69
2,823 total citations
h5-index
75
h5 depth signal
Cited share
85.4%
292 of 342
Total citations
2,823
Citation footprint
Metric signal
9.76
External metric anchor
Self-citation
2.8%
79 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
394
United Kingdom
372
Australia
331
China
230
Canada
170
Citing Fields of Research
Nutrition & Dietetics
1,162
Diabetes
386
Endocrinology & Metabolism
137
Obstetrics/Gynecology
95
Sports Science
83
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,258
Articles tracked across the journal lifetime
Indexed publication set
342
292 cited publications
Last 12 months
212
17.7 publications/month
Open access share
59.9%
127 OA publications in the last year
Leading citing country
United States
394 citing publications
Leading citing field
Nutrition & Dietetics
1,162 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v1n1, May 2000-
v1n1, May 2000-
Active Coverage
Research Focus & Classification
Indexed Subjects
Nutrition & Dietetics
Issuing & Sponsoring Bodies
Contributor
International Association for the Study of Obesity
Broad Categories
Metabolism
Nutrition & Dietetics
MeSH Descriptors
Obesity
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1111/obr.70245
Open DOI
Influence of GLP‐1‐Based Pharmacotherapies on Eating Behavior, Appetite, and Energy Intake in Adults With Overweight or Obesity: A Systematic Review and Meta‐Analysis
Introduction: Although GLP‐1‐based pharmacotherapies achieve clinically significant weight loss, their influence on eating behavior is unknown. Methods: This systematic review examined the effects of GLP‐1‐based pharmacotherapies on eati...
02
DOI 10.1111/obr.70234
Open DOI
Cost‐Effectiveness of Personalized Lifestyle Interventions in Adults With Overweight/Obesity: A Systematic Review
Objectives: Obesity and overweight pose a global health and economic burden. Lifestyle interventions are recommended as first‐line treatment. Given their individual complexity, personalized lifestyle interventions may be more effective t...
03
DOI 10.1111/obr.70239
Open DOI
Eating Behaviors, Dietary Intakes, and Other Lifestyle Behaviors as Mediators of Genetic Susceptibility to Obesity: A Systematic Review
Mediation analysis identifies variables that explain the causal pathways linking an exposure (here genetic susceptibility to obesity) to an outcome (here obesity‐related traits), offering potential targets for weight management intervent...
04
DOI 10.1111/obr.70242
Open DOI
Assessing Behavioral and Environmental Facets of Obesity Unobtrusively Utilizing Digital Tools: Introducing the BETTER4U Indicators
Understanding obesity involves evaluating numerous contributing factors. Collecting the necessary data for this can impose a significant burden on both research participants during clinical studies and real‐life deployments of digital to...
05
06
DOI 10.1111/obr.70236
Open DOI
Effectiveness of Zumba in Improving Cardiorespiratory Fitness and Anthropometric Measures Among Women With Low Physical Activity Levels: A Systematic Review and Meta‐Analysis
Background: Physical inactivity increases the risk of developing chronic illnesses. However, the effectiveness of Zumba among women who are physically inactive remains understudied. This review aims to evaluate the effectiveness of Zumba...
07
DOI 10.1111/obr.70238
Open DOI
Rethinking Obstructive Sleep Apnea Care in Obesity: Continuous Positive Airway Pressure, Incretin‐Based Therapy, or Both?
Obesity is a primary driver of obstructive sleep apnea and contributes substantially to its associated cardiovascular morbidity and mortality. Although continuous positive airway pressure remains the standard treatment, its efficacy is o...
08
DOI 10.1111/obr.70226
Open DOI
Toward “Obesityomics”: Domain‐Specific Omics in Precision Obesity Medicine with a Brief AI Perspective
Background: Obesity's global rise has outpaced the effectiveness of “one‐size‐fits‐all” prevention and treatment strategies. The promise of precision medicine lies in addressing the etiological and biological diversity of obesity and tra...
09
DOI 10.1111/obr.70237
Open DOI
Issue Information
10
DOI 10.1111/obr.70228
Open DOI
The Power of Two: Harnessing Dual Glucagon and Incretin Signaling for Treatment of Obesity and Metabolic Dysfunction–Associated Steatohepatitis—A Narrative Review with a Translational Focus
A resurgence in glucagon research has repositioned this pancreatic hormone as a promising target in the treatment of obesity and related metabolic disorders. Glucagon is classically known for contributing to glucose homeostasis, but emer...
Bibliographical & Catalog Notes
Title from cover.
Some vols. accompanied by supplements.
Also issued online.
v.1, no. 1 (Jan. 1999)20020715 Notice is published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper